Recombinant Human MIP-4 (CCL18) 0 ReviewsSubmit a Review Product Details Catalogue Number: 300-34 Description: MIP-4 is a CC chemokine that is expressed in lymph nodes, lungs, placenta and bone marrow. MIP-4's primary receptor is unknown. MIP-4 chemoattracts lymphocytes, and has been shown to exert activity on both CD4+ and CD8+ T cells. Recombinant Human MIP-4 is a 7.8 kDa protein containing 68 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. Source: E.coli Synonyms: Macrophage Inflammatory Protein-4, CCL18, PARC, DC-CK1, AMAC-1 AA Sequence: QVGTNKELCC LVYTSWQIPQ KFIVDYSETS PQCPKPGVIL LTKRGRQICA DPNKKWVQKY ISDLKLNA Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses. Biological Activity: Not available. Calculated Molecular Weight: 7.8 kDa Accession Number: P55774 Gene ID: 6362 crossreactivity: Bacteria, Human, Human + Mouse, Mouse, References PubMed SDS CoA Search Product Line Country Of Origin: USA Not for human use. Research Interest Chemotaxis Immune System Wound Healing product.subtitle.recentcitations First Author Darlot, B Title Engineered anti-inflammatory peptides inspired by mapping an evasin-chemokine interaction. Citation The Journal of Biological Chemistry; 295(32) pg10926-10939 PubMed Id 32471866 First Author Su, S Title Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages. Citation Cell; 175(2) pg442-457.e23 PubMed Id 30290143 First Author Singh, K Title Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities. Citation Scientific Reports; 7(1) pg4267 PubMed Id 28655871
